{"id":"https://openalex.org/W2608124271","doi":"https://doi.org/10.1007/s12185-017-2238-9","title":"Ponatinib in Japanese patients with Philadelphia chromosome-positive leukemia, a phase 1/2 study","display_name":"Ponatinib in Japanese patients with Philadelphia chromosome-positive leukemia, a phase 1/2 study","publication_year":2017,"publication_date":"2017-04-25","ids":{"openalex":"https://openalex.org/W2608124271","doi":"https://doi.org/10.1007/s12185-017-2238-9","mag":"2608124271","pmid":"https://pubmed.ncbi.nlm.nih.gov/28444644"},"language":"en","primary_location":{"id":"doi:10.1007/s12185-017-2238-9","doi":"https://doi.org/10.1007/s12185-017-2238-9","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s12185-017-2238-9","pdf_url":null,"source":{"id":"https://openalex.org/S45192162","display_name":"International Journal of Hematology","issn_l":"0925-5710","issn":["0925-5710","1865-3774"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Hematology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018044109","display_name":"Arinobu Tojo","orcid":"https://orcid.org/0000-0001-9016-1948","observed_orcids":["https://orcid.org/0000-0001-9016-1948"]},"institutions":[{"id":"https://openalex.org/I4405286826","display_name":"Institute of Medical Science, The University of Tokyo","ror":"https://ror.org/0376e0j29","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4405286826","https://openalex.org/I74801974"]},{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Arinobu Tojo","raw_affiliation_strings":["The Institute of Medical Science, The University Of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan. a-tojo@ims.u-tokyo.ac.jp","The Institute of Medical Science, The University Of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan"],"raw_orcid":"https://orcid.org/0000-0001-9016-1948","affiliations":[{"raw_affiliation_string":"The Institute of Medical Science, The University Of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan. a-tojo@ims.u-tokyo.ac.jp","institution_ids":["https://openalex.org/I4405286826","https://openalex.org/I74801974"]},{"raw_affiliation_string":"The Institute of Medical Science, The University Of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan","institution_ids":["https://openalex.org/I4405286826","https://openalex.org/I74801974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053476632","display_name":"Taiichi Kyo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105156","display_name":"Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital","ror":"https://ror.org/01h48bs12","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210105156"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Taiichi Kyo","raw_affiliation_strings":["Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan","institution_ids":["https://openalex.org/I4210105156"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018968800","display_name":"Kazuhito Yamamoto","orcid":"https://orcid.org/0000-0002-8588-8955","observed_orcids":["https://orcid.org/0000-0002-8588-8955"]},"institutions":[{"id":"https://openalex.org/I4405286927","display_name":"Aichi Cancer Center Hospital","ror":"https://ror.org/03kh0z432","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210133851","https://openalex.org/I4405286927"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuhito Yamamoto","raw_affiliation_strings":["Aichi Cancer Center Hospital, Aichi, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aichi Cancer Center Hospital, Aichi, Japan","institution_ids":["https://openalex.org/I4405286927"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079519158","display_name":"Hirohisa Nakamae","orcid":"https://orcid.org/0000-0003-4203-990X","observed_orcids":["https://orcid.org/0000-0003-4203-990X"]},"institutions":[{"id":"https://openalex.org/I4210166029","display_name":"Osaka City University Hospital","ror":"https://ror.org/05mxean80","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210166029"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hirohisa Nakamae","raw_affiliation_strings":["Osaka City University Hospital, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Osaka City University Hospital, Osaka, Japan","institution_ids":["https://openalex.org/I4210166029"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053502496","display_name":"Naoto Takahashi","orcid":"https://orcid.org/0000-0002-6758-3787","observed_orcids":["https://orcid.org/0000-0002-6758-3787"]},"institutions":[{"id":"https://openalex.org/I4210132405","display_name":"Akita University Hospital","ror":"https://ror.org/02szmmq82","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210132405"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Naoto Takahashi","raw_affiliation_strings":["Akita University Hospital, Akita, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Akita University Hospital, Akita, Japan","institution_ids":["https://openalex.org/I4210132405"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052874191","display_name":"Yukio Kobayashi","orcid":"https://orcid.org/0000-0003-2378-7865","observed_orcids":["https://orcid.org/0000-0003-2378-7865"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yukio Kobayashi","raw_affiliation_strings":["National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083522292","display_name":"Tetsuzo Tauchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108955","display_name":"Tokyo Medical University Hospital","ror":"https://ror.org/012e6rh19","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210108955"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tetsuzo Tauchi","raw_affiliation_strings":["Tokyo Medical University Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tokyo Medical University Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4210108955"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044647383","display_name":"Shinichiro Okamoto","orcid":"https://orcid.org/0000-0002-6257-4152","observed_orcids":["https://orcid.org/0000-0002-6257-4152"]},"institutions":[{"id":"https://openalex.org/I4210107168","display_name":"Keio University Hospital","ror":"https://ror.org/01k8ej563","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210107168"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shinichiro Okamoto","raw_affiliation_strings":["Keio University Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Keio University Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4210107168"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017936080","display_name":"Koichi Miyamura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132181","display_name":"Japanese Red Cross Nagoya Daiichi Hospital","ror":"https://ror.org/03f918r09","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I2799517759","https://openalex.org/I4210132181"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Koichi Miyamura","raw_affiliation_strings":["Japan Red Cross Nagoya Daiichi Hospital, Aichi, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Red Cross Nagoya Daiichi Hospital, Aichi, Japan","institution_ids":["https://openalex.org/I4210132181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102946326","display_name":"Kiyohiko Hatake","orcid":"https://orcid.org/0000-0002-7551-8766","observed_orcids":["https://orcid.org/0000-0002-7551-8766"]},"institutions":[{"id":"https://openalex.org/I4210137039","display_name":"The Cancer Institute Hospital","ror":"https://ror.org/03md8p445","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137039"]},{"id":"https://openalex.org/I42570316","display_name":"Japanese Foundation For Cancer Research","ror":"https://ror.org/00bv64a69","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I42570316"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kiyohiko Hatake","raw_affiliation_strings":["The Cancer Institute Hospital Japanese Foundation for Cancer Research, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Cancer Institute Hospital Japanese Foundation for Cancer Research, Tokyo, Japan","institution_ids":["https://openalex.org/I4210137039","https://openalex.org/I42570316"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060126327","display_name":"Hiromi Iwasaki","orcid":"https://orcid.org/0000-0003-3711-272X","observed_orcids":["https://orcid.org/0000-0003-3711-272X"]},"institutions":[{"id":"https://openalex.org/I4210097767","display_name":"Kyushu University Hospital","ror":"https://ror.org/00ex2fc97","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I135598925","https://openalex.org/I4210097767"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiromi Iwasaki","raw_affiliation_strings":["Kyushu University Hospital, Fukuok, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kyushu University Hospital, Fukuok, Japan","institution_ids":["https://openalex.org/I4210097767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045468227","display_name":"Itaru Matsumura","orcid":"https://orcid.org/0000-0003-2818-4270","observed_orcids":["https://orcid.org/0000-0003-2818-4270"]},"institutions":[{"id":"https://openalex.org/I4210094884","display_name":"Kindai University Hospital","ror":"https://ror.org/00qmnd673","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210094884"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Itaru Matsumura","raw_affiliation_strings":["Kinki University Hospital, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kinki University Hospital, Osaka, Japan","institution_ids":["https://openalex.org/I4210094884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111484615","display_name":"Noriko Usui","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405284262","display_name":"The Jikei University West Medical Center","ror":"https://ror.org/037y4pb78","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405284262"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Noriko Usui","raw_affiliation_strings":["The Jikei University Daisan Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Jikei University Daisan Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405284262"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113454854","display_name":"Tomoki Naoe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137409","display_name":"National Hospital Organization","ror":"https://ror.org/03ntccx93","country_code":"JP","type":"government","lineage":["https://openalex.org/I4210137409"]},{"id":"https://openalex.org/I4210152596","display_name":"Nagoya Medical Center","ror":"https://ror.org/04ftw3n55","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137409","https://openalex.org/I4210152596"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomoki Naoe","raw_affiliation_strings":["National Hospital Organization Nagoya Medical Center, Aichi, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Hospital Organization Nagoya Medical Center, Aichi, Japan","institution_ids":["https://openalex.org/I4210137409","https://openalex.org/I4210152596"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046060870","display_name":"Meera Tugnait","orcid":"https://orcid.org/0000-0002-9005-375X","observed_orcids":["https://orcid.org/0000-0002-9005-375X"]},"institutions":[{"id":"https://openalex.org/I4387156154","display_name":"ARIAD Pharmaceuticals (United States)","ror":"https://ror.org/01dwtyk53","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I4387156154","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meera Tugnait","raw_affiliation_strings":["ARIAD Pharmaceuticals, Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ARIAD Pharmaceuticals, Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I4387156154"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030594054","display_name":"Narayana I. Narasimhan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387156154","display_name":"ARIAD Pharmaceuticals (United States)","ror":"https://ror.org/01dwtyk53","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I4387156154","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Narayana I. Narasimhan","raw_affiliation_strings":["ARIAD Pharmaceuticals, Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ARIAD Pharmaceuticals, Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I4387156154"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006302059","display_name":"Stephanie Lustgarten","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387156154","display_name":"ARIAD Pharmaceuticals (United States)","ror":"https://ror.org/01dwtyk53","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I4387156154","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephanie Lustgarten","raw_affiliation_strings":["ARIAD Pharmaceuticals, Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ARIAD Pharmaceuticals, Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I4387156154"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086130517","display_name":"Heinrich D. Farin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387156154","display_name":"ARIAD Pharmaceuticals (United States)","ror":"https://ror.org/01dwtyk53","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I4387156154","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heinrich Farin","raw_affiliation_strings":["ARIAD Pharmaceuticals, Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ARIAD Pharmaceuticals, Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I4387156154"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084436319","display_name":"Frank G. Haluska","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387156154","display_name":"ARIAD Pharmaceuticals (United States)","ror":"https://ror.org/01dwtyk53","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I4387156154","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frank Haluska","raw_affiliation_strings":["ARIAD Pharmaceuticals, Inc., Cambridge, MA, USA","BioCancell Therapeutics Ltd., Jerusalem, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ARIAD Pharmaceuticals, Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I4387156154"]},{"raw_affiliation_string":"BioCancell Therapeutics Ltd., Jerusalem, Israel","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053689963","display_name":"Kazuma Ohyashiki","orcid":"https://orcid.org/0000-0003-0845-5758","observed_orcids":["https://orcid.org/0000-0003-0845-5758"]},"institutions":[{"id":"https://openalex.org/I4210108955","display_name":"Tokyo Medical University Hospital","ror":"https://ror.org/012e6rh19","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210108955"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuma Ohyashiki","raw_affiliation_strings":["Tokyo Medical University Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tokyo Medical University Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4210108955"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":18,"corresponding_author_ids":["https://openalex.org/A5018044109"],"corresponding_institution_ids":["https://openalex.org/I4405286826","https://openalex.org/I74801974"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":3.098,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.92176968,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"106","issue":"3","first_page":"385","last_page":"397"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ponatinib","display_name":"ponatinib","score":1.0},{"id":"https://openalex.org/keywords/philadelphia-chromosome-positive-leukemia","display_name":"Philadelphia chromosome-positive leukemia","score":0.9309999942779541},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/philadelphia-chromosome-positive-acute-lymphoblastic-leukemia","display_name":"Philadelphia chromosome-positive acute lymphoblastic leukemia","score":0.9739999771118164},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitor-resistance","display_name":"tyrosine kinase inhibitor resistance","score":0.9369999766349792},{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.7409999966621399},{"id":"https://openalex.org/keywords/nilotinib","display_name":"nilotinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/major-cytogenetic-response","display_name":"major cytogenetic response","score":0.8669999837875366},{"id":"https://openalex.org/keywords/arterial-occlusive-events","display_name":"arterial occlusive events","score":0.9039999842643738},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.7860000133514404},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.9139999747276306},{"id":"https://openalex.org/keywords/drug-accumulation","display_name":"drug accumulation","score":0.6079999804496765},{"id":"https://openalex.org/keywords/recommended-dose","display_name":"recommended dose","score":0.6840000152587891},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.9729999899864197}],"concepts":[{"id":"https://openalex.org/C2780381907","wikidata":"https://www.wikidata.org/wiki/Q198728","display_name":"Ponatinib","level":5,"score":0.9042395353317261},{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.816443681716919},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.804023265838623},{"id":"https://openalex.org/C2777413986","wikidata":"https://www.wikidata.org/wiki/Q412327","display_name":"Nilotinib","level":4,"score":0.7992936372756958},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7523387670516968},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7482549548149109},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5707865357398987},{"id":"https://openalex.org/C2780873365","wikidata":"https://www.wikidata.org/wiki/Q496812","display_name":"Leukopenia","level":3,"score":0.541205883026123},{"id":"https://openalex.org/C194409129","wikidata":"https://www.wikidata.org/wiki/Q103824","display_name":"Hematology","level":2,"score":0.5026977062225342},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.4495861530303955},{"id":"https://openalex.org/C2778904597","wikidata":"https://www.wikidata.org/wiki/Q1129111","display_name":"Philadelphia chromosome","level":4,"score":0.448763370513916},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.41874125599861145},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3875010907649994},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.21113520860671997},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.06967529654502869},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C138626823","wikidata":"https://www.wikidata.org/wiki/Q916504","display_name":"Chromosomal translocation","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044466","descriptor_name":"Asian People","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s12185-017-2238-9","doi":"https://doi.org/10.1007/s12185-017-2238-9","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s12185-017-2238-9","pdf_url":null,"source":{"id":"https://openalex.org/S45192162","display_name":"International Journal of Hematology","issn_l":"0925-5710","issn":["0925-5710","1865-3774"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Hematology","raw_type":"journal-article"},{"id":"pmid:28444644","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28444644","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of hematology","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G1681917860","display_name":"Development of novel anti-leukemic therapy targeting clathrin-dependent endocytosis","funder_award_id":"15K09461","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320309021","display_name":"Ariad Pharmaceuticals","ror":"https://ror.org/01dwtyk53"},{"id":"https://openalex.org/F4320309052","display_name":"Alexion Pharmaceuticals","ror":"https://ror.org/031ywxc85"},{"id":"https://openalex.org/F4320317858","display_name":"Nippon Shinyaku","ror":"https://ror.org/05wyn3p10"},{"id":"https://openalex.org/F4320321625","display_name":"Daiichi-Sankyo","ror":"https://ror.org/027y26122"},{"id":"https://openalex.org/F4320327845","display_name":"Ono Pharmaceutical","ror":"https://ror.org/022jefx64"},{"id":"https://openalex.org/F4320333003","display_name":"Chugai Pharmaceutical","ror":"https://ror.org/01vepzj85"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"},{"id":"https://openalex.org/F4320338262","display_name":"Daiichi Sankyo Europe","ror":"https://ror.org/01qhj1g70"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1952424916","https://openalex.org/W1965749310","https://openalex.org/W1993170960","https://openalex.org/W1994309500","https://openalex.org/W2015497660","https://openalex.org/W2021033166","https://openalex.org/W2028959752","https://openalex.org/W2032344621","https://openalex.org/W2044042722","https://openalex.org/W2068117867","https://openalex.org/W2076418211","https://openalex.org/W2091005492","https://openalex.org/W2097799776","https://openalex.org/W2104694028","https://openalex.org/W2104983860","https://openalex.org/W2110648386","https://openalex.org/W2115626434","https://openalex.org/W2147109509","https://openalex.org/W2261840157","https://openalex.org/W2478829584","https://openalex.org/W2495072828","https://openalex.org/W2579924100","https://openalex.org/W2640929241","https://openalex.org/W2763319969","https://openalex.org/W4250856334"],"related_works":["https://openalex.org/W78746003","https://openalex.org/W3159331896","https://openalex.org/W4405047837","https://openalex.org/W2147109509","https://openalex.org/W2603087458","https://openalex.org/W2603378557","https://openalex.org/W3194203975","https://openalex.org/W2600040265","https://openalex.org/W2553120495","https://openalex.org/W2978352165"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-05-05T00:00:00"}